This data is consistent with the report of Lee et al. in prostate cancer [41], which more fully demonstrates that ZFP36 prevents tumor cell growth in the G1 phase by negatively regulating CDK6 and cyclins. The gene discussed is CDK6; the disease is prostate carcinoma.